Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Roka Bioscience, Inc.
Oklahoma City, OK (December 29, 2014) – On December 24, 2014, a class action lawsuit was filed in the United States District Court for the District of New Jersey against Roka Bioscience, Inc. (NASDAQ: ROKA) (the “Company”). The complaint that the Company’s initial public offering (the “IPO”) documents failed to disclose known trends and uncertainties about the decline in demand for its Atlas instruments.
On November 6, 2014, the Company announced a net loss of $0.64 per share in the third quarter of 2014. The Company admitted that it had not placed any Atlas instruments in that quarter. On this news, the Company’s shares declined to close at $3.00 per share.
Plaintiff seeks to recover damages on behalf of all Roka Bioscience, Inc. shareholders who purchased common stock traceable to the IPO between July 17, 2014 and November 6, 2014 (the “Class Period”) and are therefore a member of the Class as described above. You may move the Court no later than Monday, February 23, 2015 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
To join this class action, click hereto obtain an investor certification. Once complete, please email this form to email@example.com, fax to us at (405) 239-2112 or send by regular mail to Federman & Sherwood, 10205 North Pennsylvania Avenue, Oklahoma City, OK 73120, ATTN: Robin.
Posted on Mon, December 29, 2014
by Robin Hester filed under